These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 33285640)

  • 21. Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia.
    Beach TG; Adler CH; Zhang N; Serrano GE; Sue LI; Driver-Dunckley E; Mehta SH; Zamrini EE; Sabbagh MN; Shill HA; Belden CM; Shprecher DR; Caselli RJ; Reiman EM; Davis KJ; Long KE; Nicholson LR; Intorcia AJ; Glass MJ; Walker JE; Callan MM; Oliver JC; Arce R; Gerkin RC
    PLoS One; 2020; 15(4):e0231720. PubMed ID: 32320406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter clinicopathological correlation in dementia.
    Victoroff J; Mack WJ; Lyness SA; Chui HC
    Am J Psychiatry; 1995 Oct; 152(10):1476-84. PubMed ID: 7573587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.
    Toledo JB; Arnold SE; Raible K; Brettschneider J; Xie SX; Grossman M; Monsell SE; Kukull WA; Trojanowski JQ
    Brain; 2013 Sep; 136(Pt 9):2697-706. PubMed ID: 23842566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
    Brenowitz WD; Keene CD; Hawes SE; Hubbard RA; Longstreth WT; Woltjer RL; Crane PK; Larson EB; Kukull WA
    Neurobiol Aging; 2017 May; 53():83-92. PubMed ID: 28236716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
    Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
    Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
    McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
    Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview.
    Matej R; Tesar A; Rusina R
    Clin Biochem; 2019 Nov; 73():26-31. PubMed ID: 31400306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
    Davidson YS; Raby S; Foulds PG; Robinson A; Thompson JC; Sikkink S; Yusuf I; Amin H; DuPlessis D; Troakes C; Al-Sarraj S; Sloan C; Esiri MM; Prasher VP; Allsop D; Neary D; Pickering-Brown SM; Snowden JS; Mann DM
    Acta Neuropathol; 2011 Dec; 122(6):703-13. PubMed ID: 21968532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
    Katsumata Y; Fardo DW; Kukull WA; Nelson PT
    Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias.
    Yarchoan M; Xie SX; Kling MA; Toledo JB; Wolk DA; Lee EB; Van Deerlin V; Lee VM; Trojanowski JQ; Arnold SE
    Brain; 2012 Dec; 135(Pt 12):3749-56. PubMed ID: 23204143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of machine learning models to detect amyloid pathologies across institutions.
    Vizcarra JC; Gearing M; Keiser MJ; Glass JD; Dugger BN; Gutman DA
    Acta Neuropathol Commun; 2020 Apr; 8(1):59. PubMed ID: 32345363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dementia from Alzheimer disease and mixed pathologies in the oldest old.
    James BD; Bennett DA; Boyle PA; Leurgans S; Schneider JA
    JAMA; 2012 May; 307(17):1798-800. PubMed ID: 22550192
    [No Abstract]   [Full Text] [Related]  

  • 38. Hippocampal sclerosis of aging is a key Alzheimer's disease mimic: clinical-pathologic correlations and comparisons with both alzheimer's disease and non-tauopathic frontotemporal lobar degeneration.
    Brenowitz WD; Monsell SE; Schmitt FA; Kukull WA; Nelson PT
    J Alzheimers Dis; 2014; 39(3):691-702. PubMed ID: 24270205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging.
    Bachstetter AD; Van Eldik LJ; Schmitt FA; Neltner JH; Ighodaro ET; Webster SJ; Patel E; Abner EL; Kryscio RJ; Nelson PT
    Acta Neuropathol Commun; 2015 May; 3():32. PubMed ID: 26001591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders.
    Jellinger KA; Attems J
    Dement Geriatr Cogn Disord; 2011; 31(4):309-16. PubMed ID: 21502762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.